RAPT Therapeutics, Inc. Comprehensive Income
RAPT Therapeutics, Inc. reported Comprehensive Income of -$17.50 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-11-06
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$17.50M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$17.66M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$17.18M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$53.31M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$129.92M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$116.67M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$83.66M.
- RAPT Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$69.23M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$17.50M 10-Q · filed 2025-11-06 | -$35.16M derived: sum of 2 quarters · filed 2025-11-06 | -$52.34M 10-Q · filed 2025-11-06 | -$105.64M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$17.66M 10-Q · filed 2025-08-07 | -$34.84M 10-Q · filed 2025-08-07 | -$88.15M derived: sum of 3 quarters · filed 2025-08-07 | -$106.43M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$17.18M 10-Q · filed 2025-05-08 | -$70.49M derived: sum of 2 quarters · filed 2025-05-08 | -$88.76M derived: sum of 3 quarters · filed 2025-11-06 | -$116.46M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$53.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$71.58M derived: sum of 2 quarters · filed 2025-11-06 | -$99.28M derived: sum of 3 quarters · filed 2025-11-06 | -$129.92M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$18.28M 10-Q · filed 2025-11-06 | -$45.98M derived: sum of 2 quarters · filed 2025-11-06 | -$76.61M 10-Q · filed 2025-11-06 | -$107.26M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$27.70M 10-Q · filed 2025-08-07 | -$58.33M 10-Q · filed 2025-08-07 | -$88.99M derived: sum of 3 quarters · filed 2025-08-07 | -$120.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$30.63M 10-Q · filed 2025-05-08 | -$61.29M derived: sum of 2 quarters · filed 2025-05-08 | -$92.60M derived: sum of 3 quarters · filed 2025-05-08 | -$118.40M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$30.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$61.96M derived: sum of 2 quarters · filed 2025-03-06 | -$87.76M derived: sum of 3 quarters · filed 2025-03-06 | -$116.67M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$31.31M 10-Q · filed 2024-11-12 | -$57.11M derived: sum of 2 quarters · filed 2024-11-12 | -$86.02M 10-Q · filed 2024-11-12 | -$108.54M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$25.80M 10-Q · filed 2024-08-08 | -$54.70M 10-Q · filed 2024-08-08 | -$77.23M derived: sum of 3 quarters · filed 2024-08-08 | -$98.17M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$28.91M 10-Q · filed 2024-05-09 | -$51.43M derived: sum of 2 quarters · filed 2024-05-09 | -$72.37M derived: sum of 3 quarters · filed 2024-05-09 | -$91.19M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$22.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$43.47M derived: sum of 2 quarters · filed 2024-03-07 | -$62.28M derived: sum of 3 quarters · filed 2024-03-07 | -$83.66M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$20.94M 10-Q · filed 2023-11-13 | -$39.76M derived: sum of 2 quarters · filed 2023-11-13 | -$61.13M 10-Q · filed 2023-11-13 | -$79.31M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$18.81M 10-Q · filed 2023-08-11 | -$40.19M 10-Q · filed 2023-08-11 | -$58.37M derived: sum of 3 quarters · filed 2023-08-11 | -$76.84M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$21.38M 10-Q · filed 2023-05-11 | -$39.56M derived: sum of 2 quarters · filed 2023-05-11 | -$58.03M derived: sum of 3 quarters · filed 2023-05-11 | -$74.09M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$36.65M derived: sum of 2 quarters · filed 2023-03-14 | -$52.71M derived: sum of 3 quarters · filed 2023-03-14 | -$69.23M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$18.47M 10-Q · filed 2022-11-10 | -$34.53M derived: sum of 2 quarters · filed 2022-11-10 | -$51.05M 10-Q · filed 2022-11-10 | -$64.04M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$16.06M 10-Q · filed 2022-08-11 | -$32.58M 10-Q · filed 2022-08-11 | -$45.57M derived: sum of 3 quarters · filed 2022-08-11 | -$60.30M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$16.53M 10-Q · filed 2022-05-11 | -$29.51M derived: sum of 2 quarters · filed 2022-05-11 | -$44.25M derived: sum of 3 quarters · filed 2022-05-11 | -$56.46M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$27.72M derived: sum of 2 quarters · filed 2022-03-10 | -$39.94M derived: sum of 3 quarters · filed 2022-03-10 | -$53.09M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$14.73M 10-Q · filed 2021-11-10 | -$26.95M derived: sum of 2 quarters · filed 2021-11-10 | -$40.10M 10-Q · filed 2021-11-10 | -$53.31M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$12.22M 10-Q · filed 2021-08-11 | -$25.37M 10-Q · filed 2021-08-11 | -$38.58M derived: sum of 3 quarters · filed 2021-08-11 | -$48.53M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$13.15M 10-Q · filed 2021-05-11 | -$26.36M derived: sum of 2 quarters · filed 2021-05-11 | -$36.32M derived: sum of 3 quarters · filed 2021-05-11 | -$46.94M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$13.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$23.16M derived: sum of 2 quarters · filed 2021-03-11 | -$33.79M derived: sum of 3 quarters · filed 2021-03-11 | -$42.97M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$9.96M 10-Q · filed 2020-11-16 | -$20.58M derived: sum of 2 quarters · filed 2020-11-16 | -$29.76M 10-Q · filed 2020-11-16 | -$39.20M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$10.62M 10-Q · filed 2020-08-13 | -$19.81M 10-Q · filed 2020-08-13 | -$29.24M derived: sum of 3 quarters · filed 2020-08-13 | -$39.53M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$9.19M 10-Q · filed 2020-05-14 | -$18.62M derived: sum of 2 quarters · filed 2020-05-14 | -$28.91M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$19.72M derived: sum of 2 quarters · filed 2020-03-30 | -$36.15M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$10.29M 10-Q · filed 2019-12-11 | -$26.72M 10-Q · filed 2019-12-11 |